Industry Segment and Operations by Geographic Areas (Tables)

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Summary of Revenues by Customer Location

Revenues by customer location are summarized as follows:

	Three Months Ended March 31,
	2014		2013
United States of America	$	3,914,659	$	3,527,287
Europe		1,085,096		933,639
Other		202,440		67,296
	$	5,202,195	$	4,528,222

Summary of Revenues by Product Type

Revenues by product type:

	Three Months Ended March 31,
	2014		2013
Injection products	$	4,806,782	$	3,436,500
Transdermal gel products		395,413		1,091,722
	$	5,202,195	$	4,528,222

Summary of Significant Customers Comprising 10% or More of Total Revenue

Significant customers comprising 10% or more of total revenue are as follows:

	Three Months Ended March 31,
	2014		2013
Teva	$	2,448,287	$	2,455,266
Ferring		1,085,096		933,639
LEO Pharma		857,143		—
Actavis		166,627		874,328